© Grace Therapeutics, Inc. All Rights Reserved.

Our products result from novel and unique drug delivery solutions that address inadequately treated rare and orphan diseases and those for which no treatment exists.

What we do?

Our Products

Post Herpetic Neuralgia (PHN) - Topical Spray

PHN is neuropathic pain caused by nerve damage from the varicella zoster virus. This pain may persist for months and even years. PHN is a rare and orphan condition, which affects an estimated 180,000 patients per year in the US.

Visit National Shingles Foundation to learn more about PHN.

Ataxia-telangiectasia (A-T) - Oral Mucosal Spray

A-T is a progressive, neurodegenerative genetic disease that primarily impacts children causing severe disability. A-T affects many parts of the body including areas of the brain, causing difficulty with motor function and motion. The disease is also associated with weakening of the immune system predisposing to infection, and with faulty repair of damaged DNA increasing the risk of cancer. A-T is a rare and orphan condition which affects an estimated 2,500 patients per year in the US.

Visit A-T Children's Project to learn more about A-T.

Subarachnoid Hemorrhage (SAH) - Intravenous Infusion

SAH is a rare and life threatening medical emergency in which bleeding occurs over the surface of the brain in the subarachnoid space between the brain and skull. A primary cause of such hemorrhage is rupture of an aneurysm or ballooning of a weakened blood vessel wall. SAH affects an estimated 40,000 patients per year in the US.

Visit Brain Aneurysm Foundation to learn more about SAH.